Best Biotech Stocks For 2019

What happened

Spark Therapeutics (NASDAQ:ONCE) stock outpaced the market by a wide margin last month, gaining 137% compared to a 3% spike in the S&P 500, according to data provided by S&P Global Market Intelligence.

The increase put shareholders back in significantly positive territory, with returns of over 70% in the past year versus a 3% increase in the broader market.

Image source: Getty Images.

So what

Last month’s rally came as a result of the biotech company announcing an agreement to be purchased by Roche Holdings (NASDAQOTH:RHHBY) for nearly $5 billion, or $114.50 per share. That price equates to a 122% premium over the stock’s value on trading day prior to the deal’s announcement .

Now what

Spark Therapeutics shareholders should see their stock holdings convert to cash at that $114.50 price when the deal closes sometime in the second quarter of 2019. After that, the company will continue to operate as an independent group within Roche Holdings, but will benefit from its parent’s global reach as it seeks to better commercialize treatments like its Luxturna genetic eye disease drug. That deal ensures positive returns for all shareholders, which counts as a solid win in the volatile biotech world.

Best Biotech Stocks For 2019: Spirit Airlines Inc.(SAVE)

Advisors’ Opinion:

  • [By Adam Levine-Weinberg]

    The oil rally has cooled off this month, over recent reports that have alleviated investors’ worries about a serious oil shortage. Lower jet fuel prices should help all of the airlines, but two could benefit disproportionately: Spirit Airlines (NYSE:SAVE) and Alaska Air (NYSE:ALK).

  • [By Adam Levine-Weinberg]

    In late 2016, I wrote that shares of Spirit Airlines (NYSE:SAVE) could reach $100 by 2020. Since then, there’s been a lot of movement — both up and down — for Spirit Airlines stock, but the share price is almost exactly back where it started.

  • [By Rich Duprey, Daniel Miller, and Steve Symington]

    Yet three Motley Fool contributors identified iRobot (NASDAQ:IRBT), Spirit Airlines (NYSE:SAVE), and Sturm, Ruger (NYSE:RGR) as opportunities that could deliver long-term payoffs.

  • [By Lee Jackson]

    The company is an ultra-low-cost carrier that sold off big from the 2017 highs and is still offering investors an excellent entry point. Spirit Airlines Inc. (NASDAQ: SAVE) is based in Mirimar, Florida, and fundamentally focused on providing the lowest available fares to consumers on routes in which it serves.

Best Biotech Stocks For 2019: Digital Ally Inc.(DGLY)

Advisors’ Opinion:

  • [By Max Byerly]

    Digital Ally (NASDAQ:DGLY) was upgraded by equities researchers at ValuEngine from a “hold” rating to a “buy” rating in a research note issued to investors on Tuesday.

  • [By Max Byerly]

    Press coverage about Digital Ally (NASDAQ:DGLY) has trended somewhat positive on Tuesday, Accern Sentiment Analysis reports. Accern ranks the sentiment of news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Digital Ally earned a media sentiment score of 0.03 on Accern’s scale. Accern also assigned news coverage about the scientific and technical instruments company an impact score of 45.1932077082068 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.

  • [By Logan Wallace]

    Digital Ally (NASDAQ:DGLY)‘s stock had its “buy” rating reiterated by equities research analysts at Westpark Capital in a research note issued on Wednesday. They currently have a $5.00 target price on the scientific and technical instruments company’s stock. Westpark Capital’s price objective indicates a potential upside of 17.65% from the company’s current price.

Best Biotech Stocks For 2019: Pinnacle Financial Partners, Inc.(PNFP)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Penn Capital Management Co. Inc. raised its holdings in shares of Pinnacle Financial Partners (NASDAQ:PNFP) by 22.6% in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 41,475 shares of the financial services provider’s stock after purchasing an additional 7,651 shares during the quarter. Penn Capital Management Co. Inc. owned 0.05% of Pinnacle Financial Partners worth $2,768,000 at the end of the most recent quarter.

  • [By Logan Wallace]

    Pinnacle Financial Partners (NASDAQ:PNFP) – Analysts at Piper Jaffray Companies dropped their Q2 2018 EPS estimates for shares of Pinnacle Financial Partners in a report released on Friday, June 8th. Piper Jaffray Companies analyst W. Curtiss now expects that the financial services provider will post earnings per share of $1.16 for the quarter, down from their prior estimate of $1.17. Piper Jaffray Companies also issued estimates for Pinnacle Financial Partners’ Q3 2018 earnings at $1.21 EPS and Q1 2019 earnings at $1.23 EPS.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Pinnacle Financial Partners (PNFP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Pinnacle Financial Partners (PNFP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com